Microbiology

  1. Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives

    1. Ritesh Tandon
    2. Joshua S. Sharp
    3. Fuming Zhang
    4. Vitor H. Pomin
    5. Nicole M. Ashpole
    6. Dipanwita Mitra
    7. Martin G. McCandless
    8. Weihua Jin
    9. Hao Liu
    10. Poonam Sharma
    11. Robert J. Linhardt

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Cross-Sectional Evaluation of Humoral Responses against SARS-CoV-2 Spike

    1. Jérémie Prévost
    2. Romain Gasser
    3. Guillaume Beaudoin-Bussières
    4. Jonathan Richard
    5. Ralf Duerr
    6. Annemarie Laumaea
    7. Sai Priya Anand
    8. Guillaume Goyette
    9. Mehdi Benlarbi
    10. Shilei Ding
    11. Halima Medjahed
    12. Antoine Lewin
    13. Josée Perreault
    14. Tony Tremblay
    15. Gabrielle Gendron-Lepage
    16. Nicolas Gauthier
    17. Marc Carrier
    18. Diane Marcoux
    19. Alain Piché
    20. Myriam Lavoie
    21. Alexandre Benoit
    22. Vilayvong Loungnarath
    23. Gino Brochu
    24. Elie Haddad
    25. Hannah D. Stacey
    26. Matthew S. Miller
    27. Marc Desforges
    28. Pierre J. Talbot
    29. Graham T. Gould Maule
    30. Marceline Côté
    31. Christian Therrien
    32. Bouchra Serhir
    33. Renée Bazin
    34. Michel Roger
    35. Andrés Finzi

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Rapid inactivation of SARS-CoV-2 with Deep-UV LED irradiation

    1. Hiroko Inagaki
    2. Akatsuki Saito
    3. Hironobu Sugiyama
    4. Tamaki Okabayashi
    5. Shouichi Fujimoto

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Identification of unique mutations in SARS-CoV-2 strains isolated from India suggests its attenuated pathotype

    1. Shubham Gaurav
    2. Shambhavi Pandey
    3. Apurvasinh Puvar
    4. Tejas Shah
    5. Madhvi Joshi
    6. Chaitanya Joshi
    7. Sachin Kumar

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Comparative study of four SARS-CoV-2 Nucleic Acid Amplification Test (NAAT) platforms demonstrates that ID NOW performance is impaired substantially by patient and specimen type

    1. Paul R. Lephart
    2. Michael A. Bachman
    3. William LeBar
    4. Scott McClellan
    5. Karen Barron
    6. Lee Schroeder
    7. Duane W. Newton

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Real-time sharing of drug screening data on the NCATS OpenData Portal accelerates translational research

    1. Kyle R. Brimacombe
    2. Peter C. Scully
    3. Tongan Zhao
    4. Richard T. Eastman
    5. Xin Hu
    6. Ke Wang
    7. Mark Backus
    8. Bolormaa Baljinnyam
    9. Catherine Z. Chen
    10. Lu Chen
    11. Yichen Cheng
    12. Danielle P. Davis
    13. Kevin Duerr
    14. Tara Eicher
    15. Aaron Friedman
    16. Ying Fu
    17. Kirill Gorshkov
    18. Hui Guo
    19. Quinlin M. Hanson
    20. Nathan Hotaling
    21. Zina Itkin
    22. Stephen C. Kales
    23. Carleen Klumpp-Thomas
    24. Emily M. Lee
    25. Sam Michael
    26. Tim Mierzwa
    27. Brian Nezhad
    28. Andrew Patt
    29. Brittany J. Poelaert
    30. Manisha Pradhan
    31. Alex Renn
    32. Paul Shinn
    33. Jonathan H. Shrimp
    34. Therese N. Tripler
    35. Amit Viraktamath
    36. Kanny K. Wan
    37. Kelli M. Wilson
    38. Miao Xu
    39. Alexey V. Zakharov
    40. Wei Zhu
    41. Wei Zheng
    42. Anton Simeonov
    43. Ewy A. Mathé
    44. Marc Ferrer
    45. Donald C. Lo
    46. Min Shen
    47. Matthew D. Hall

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Nanozyme chemiluminescence paper test for rapid and sensitive detection of SARS-CoV-2 antigen

    1. Dan Liu
    2. Chenhui Ju
    3. Chao Han
    4. Rui Shi
    5. Xuehui Chen
    6. Demin Duan
    7. Jinghua Yan
    8. Xiyun Yan

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Several FDA-Approved Drugs Effectively Inhibit SARS-CoV-2 Infection in vitro

    1. Hua-Long Xiong
    2. Jia-Li Cao
    3. Chen-Guang Shen
    4. Jian Ma
    5. Xiao-Yang Qiao
    6. Tian-Shu Shi
    7. Sheng-Xiang Ge
    8. Hui-Ming Ye
    9. Jun Zhang
    10. Quan Yuan
    11. Tian-Ying Zhang
    12. Ning-Shao Xia

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. SARS-CoV-2 Is Restricted by Zinc Finger Antiviral Protein despite Preadaptation to the Low-CpG Environment in Humans

    1. Rayhane Nchioua
    2. Dorota Kmiec
    3. Janis A. Müller
    4. Carina Conzelmann
    5. Rüdiger Groß
    6. Chad M. Swanson
    7. Stuart J. D. Neil
    8. Steffen Stenger
    9. Daniel Sauter
    10. Jan Münch
    11. Konstantin M. J. Sparrer
    12. Frank Kirchhoff

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Integrated genomic view of SARS-CoV-2 in India

    1. Pramod Kumar
    2. Rajesh Pandey
    3. Pooja Sharma
    4. Mahesh S. Dhar
    5. Vivekanand A.
    6. Bharathram Uppili
    7. Himanshu Vashisht
    8. Saruchi Wadhwa
    9. Nishu Tyagi
    10. Saman Fatihi
    11. Uma Sharma
    12. Priyanka Singh
    13. Hemlata Lall
    14. Meena Datta
    15. Poonam Gupta
    16. Nidhi Saini
    17. Aarti Tewari
    18. Bibhash Nandi
    19. Dhirendra Kumar
    20. Satyabrata Bag
    21. Deepanshi Gahlot
    22. Surabhi Rathore
    23. Nidhi Jatana
    24. Varun Jaiswal
    25. Hema Gogia
    26. Preeti Madan
    27. Simrita Singh
    28. Prateek Singh
    29. Debasis Dash
    30. Manju Bala
    31. Sandhya Kabra
    32. Sujeet Singh
    33. Mitali Mukerji
    34. Lipi Thukral
    35. Mohammed Faruq
    36. Anurag Agrawal
    37. Partha Rakshit

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 63 of 255 Next